ReleaseWire Connect

The Asia Pacific Retractable Needle Safety Syringes market exhibits a quite consolidated vendor landscape, as found by a new market intelligence report by Transparency Market Research (TMR). The four of the top players, namely, Retractable Technologies Inc., Smiths Medical, Medtronic Plc, Dickinson and Co., and Becton held around more than 95% of the said market in the year 2015.

The international market for surgical sutures comprise a to a large extent a combined and consolidated vendor scene, with the top five companies holding for more than 65% of the total market in the year 2015, discovers Transparency Market Research (TMR) in its current report. The market makes an inclusion of an increasing price war because of the increase of numerous household players making an offer of items at low costs. These market players, particularly Cardinal Health, Medela AG, Integra LifeSciences Corporation, Acelity L.P. Inc., and Smith and Nephew plc dominate the global market for surgical sutures market with the help of product diversification and innovation and sound relationship with their clientele.

Other than the emergence of a few major players, the worldwide vascular grafts market is home to numerous littler organizations and a couple of nearby makers of implantable gadgets. Notwithstanding the nearness of an extensive number of undertakings, just a modest bunch of them hold strength in the worldwide vascular grafts market. Organizations, for example, B. Braun Melsungen AG, MAQUET Holding B.V. and Co. KG (Getinge AB), CRYOLIFE, INC., W. L. Gut and Associates, Inc., C.R. Poet, Vascutek Ltd. (Terumo Company), Cook Medical, Inc., Medtronic plc, LeMaitre Vascular, Inc., constituted about 93.5% of the general market in 2016. Given the situation, the worldwide vascular grafts market displays extraordinary aggressive contention among the key undertakings. The market features broad endeavors with respect to makers to enhance novel levels of vascular grafts. Their innovative work endeavors are for the most part focused at beating concerns, inconveniences, and contaminations related with the utilization of vascular grafts.

The global phototherapy equipment market is highly competitive in nature and is expected to witness an increased level of competition throughout the forecast period, states a new research report by Transparency Market Research. The leading players in the market, namely Drägerwerk AG & Co. KGaA, Herbert Waldmann GmBH & Co. KG, Phoenix Medical Systems Pvt. Ltd, Natus Medical Incorporated, GE Healthcare, Atom Medical Corporation, and The Daavlin Company are emphasizing on research and development activities in order to lunch new products in the coming years. In addition, these players are entering into collaborations with end users and provide them support in the form of insurance reimbursement, equipment refurbished services, and post-sale services in order to maintain their position and penetration in the phototherapy equipment market in the coming years.

The market for healthcare informatics and patient monitoring in India is characterized by stiff competition among the existing numerous players. Currently the market is fragmented in nature on account of the presence of a copious number of local as well as international players. Some of the key players operating in the market are Mindray Medical India Pvt. Ltd., Philips India Ltd., Wipro GE Healthcare, Nihon Kohden India Pvt. Ltd., BPL Medical Technologies Pvt. Ltd., Schiller Healthcare India Pvt. Ltd., Dräger India Pvt. Ltd., and India Medtronic Pvt. Ltd. The robust competition in the market is predicted to catalyze its phenomenal growth.

With a handful of established players, the global cell expansion market demonstrates a consolidated structure, states a new report by Transparency Market Research (TMR). The top eight companies, namely, Merck Millipore, Thermo Fisher Scientific, GE Healthcare, Danaher Corp., Becton, Dickinson and Co., Lonza, and Corning, collectively held nearly 79% of the overall market in 2016. To strengthen their presence in the worldwide cell expansion market, the leading players have increased the investment in the research activities in order to develop novel cell lines and discover new applications. Going forward, the focus of these companies will shift to product differentiation in the near future, making the competitive environment much stiff.

The global electronic health records market is foreseen to witness a laudable growth in the coming years of forecast period from 2017 to 2025, owing to rise in digitalization all across the globe. Athenahealth, Inc., Allscripts Healthcare Solutions, Inc., Cerner Corporation, eClinicalWorks, CPSI, Epic Systems, GE Healthcare, Medical Information Technology, Inc., Greenway Health, LLC, McKesson Corporation, 4medica, and NextGen Healthcare are among the leading organizations dominating the global market. The global electronic health records market is highly focused due to emergence of well-known players in the market. In this market, the key players are reliably putting resources into research to create advanced healthcare IT solutions. The established vendors are continuously dealing with solid competition from the new firms that are able to provide cloud-based electronic health records systems. The competition between the players is anticipated to heighten with increase in mergers and acquisitions and the consolidation of the market.

The global market for genomics personalized health is largely occupied by some of the leading vendors, observes a new report by Transparency Market Research (TMR). The topnotch players that include QIAGEN, Thermofisher Scientific, F. Hoffman-La Roche Ltd., and Illumina Inc. held close to 65% of the market in 2016. The market, however, displays intense competition among market participants in a bid to garner larger market share. Key market players are pouring in money into research and development to cater to the rising demand for technologically advanced tests.

Transparency Market Research (TMR) observes in a research report that the competitive landscape in the global apheresis market is likely to be intense owing to the fact that a few leading vendors hold a substantial share in the market. The future threat arising from new entrants is likely to be comparatively low over the coming years because of the license required for manufacturing equipment, technical expertise needed to venture into this field, and expensive nature of the manufacturing process, which is keeping the new players at bay. The focus on mergers, collaborations, and strategic collaborations is likely to be high in the coming years with leading companies looking forward to tighten their grip in the intensely competitive market and amid the growing cost related pressures. The leading companies in the market comprise B. Braun Melsungen AG, Cerus Corporation, Fresenius Kabi AG, Haemonetics Corporation, Terumo Corporation, and Asahi Kasei Medical Co. Ltd.

The world market for gastrointestinal stents has been assessed by a recent publication by Transparency Market Research. The market has been characterized with the presence of a few market players and is considered to be highly consolidated. The world gastrointestinal stents market is dominated by Boston Scientific Corporation and it held around 66.2% share of the total market in the year 2016. The same market, however, features fragmentation owing to the existence of numerous large scale and small scale players that are operational at both global and regional levels.